Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth

When looking for MedTech export distributors, how do you know which ones are actually right for your product and commercialisation strategy?

As a clinician founder looking to commercialise your MedTech product in international markets, finding an export distributor can feel like one of the biggest challenges. But identifying companies willing to distribute your product isn't the same as finding partners capable of helping you achieve your commercial goals.

Attending exhibitions, collecting business cards and contacting potential distributors might generate plenty of conversations, but how do you know whether you're speaking to the right people?

You're ready to sell your MedTech product, but have you considered whether your customers are actually ready to buy?

As a clinician founder looking to commercialise your MedTech product in export markets, it's natural to want to generate sales as quickly as possible. After years of product development, clinical validation and regulatory approval, the pressure to start generating revenue can be enormous.

But your urgency to sell doesn't necessarily match your customer's readiness to buy. Hospitals and healthcare organisations have their own purchasing processes, budget cycles, decision-makers and competing priorities. Even when clinicians are enthusiastic...

You've appointed an export distributor for your MedTech product, but how do you get them to prioritise selling it over the other products in their portfolio?

As a clinician founder looking to commercialise your MedTech product in international markets, appointing an export distributor is an important milestone. But securing a distribution agreement doesn't guarantee sales.

Your distributor may already represent several established medical device companies, each competing for their time, attention and resources. So how do you make sure your product doesn't get overlooked?

In this episode, Hakeem speaks with Nishant Varmer about...

When choosing an export market for your MedTech product, are you basing your sales forecast on evidence or assumptions?

When you're a clinician founder looking to commercialise your MedTech product in export markets, identifying a large market can make your sales forecasts look incredibly attractive. After all, capturing just 1% of a £100 million market would generate £1 million in revenue. But market size doesn't tell you who will buy your medical device, why they'll choose it, how you'll reach them or how long it will take to generate those sales. In this episode, Hakeem explores why relying on market sh...

As a clinician founder, how do you know when your MedTech business is genuinely ready to scale?

Growing your MedTech business isn't simply about acquiring more customers, appointing more distributors or entering new export markets. Before you scale, you need to know whether your existing customers are successfully adopting your product and whether you have a commercial model that can deliver those results repeatedly. In this episode, Hakeem speaks with Spencer Jones, a nurse turned MedTech entrepreneur and CEO of Lapovations, about why building a strong foundation for growth can be more important than expanding too quickly.<...

How long should you keep pursuing a potential MedTech customer before deciding your time might be better spent elsewhere?

When you're trying to grow MedTech sales in export markets, every potential customer can feel like an opportunity worth pursuing. But an enthusiastic meeting, a request for a proposal or repeated assurances of interest don't necessarily mean a sale is going to happen. In this episode, Hakeem explores how to distinguish genuine sales opportunities from customer interest, what to do when promising deals stop progressing, and why knowing when to redirect your efforts can be an important part...

If an overseas distributor approached you tomorrow wanting to sell your MedTech product, how would you decide whether that market was worth entering?

An unexpected enquiry from an overseas distributor can feel like an exciting opportunity to grow your MedTech business internationally. But distributor interest alone doesn't tell you whether the market is commercially attractive, whether it's the right priority or what it will take to succeed there. In this episode, Hakeem shares a real client scenario and explains why successful MedTech exporting requires a deliberate market entry strategy rather than simply reacting to opportunities as they...

Before spending thousands on your next MedTech export exhibition, how do you know whether it's actually worth the investment?

International exhibitions can be a valuable part of your MedTech export strategy, whether you're looking for distributors, entering new markets or growing existing sales. But attending the same exhibitions year after year doesn't necessarily mean they're delivering commercial value. In this episode, Hakeem explores why exhibitions should be treated as a deliberate commercial investment, how to decide whether they're the right activity for your business, and why measuring their return should start before you book the stand.

When choosing an export distributor for your MedTech product, is bigger always better?

Finding a distributor with a large sales team, an established customer base and an impressive portfolio can look like the safest route into an export market. But size doesn't necessarily mean your MedTech product will get the attention, commitment or resources it needs. In this episode, Hakeem speaks with Beau Zorn about what really matters when selecting an export distributor—and why the right partner may not be the biggest name in the market.

In this episode you'll discover:

If so many MedTech companies still struggle to achieve commercial success in export markets, are we asking the right question about why?

MedTech companies have access to more market intelligence, better technology, stronger data and more commercial expertise than ever before. Yet innovative medical devices with regulatory approval, clinical evidence and significant investment can still struggle to achieve meaningful commercial success in export markets. In this episode, Hakeem asks whether the problem is really how well companies execute their commercialisation strategy—or whether it's time to question the playbook itself.

In this episode you'll discover:

Could asking your MedTech export distributors for less actually help you get better performance from them?

When you want better performance from your export distributors, it's tempting to ask for more reports, KPIs, forecasts, CRM updates and meetings. But distributors are often managing multiple manufacturer relationships, and adding more administration doesn't necessarily give you better visibility or improve results. In this episode, Hakeem explores why simplifying what you ask your distributors to report could lead to better information, stronger commercial conversations and a more productive relationship.

What you'll discover in this episode:

What if there were a clearer route for taking your MedTech product from NHS evaluation to adoption and wider scale?

Getting your MedTech product successfully evaluated in the NHS doesn't automatically create a route to market. The harder challenge is turning that evidence into procurement, funding, routine adoption and eventually wider NHS scale. In this episode, Hakeem explores the newly announced Manchester Sandbox, why its ambition could help bridge this commercialisation gap, and the questions that still need answering.

In this episode you'll discover:

If your NHS clinical trial is successful, do you already know what needs to happen next for your MedTech product to actually get adopted?

Getting an NHS clinician interested in trialling your MedTech product can feel like a major commercial milestone. But the trial itself isn't the end goal. Before committing to a start date, you need to understand the stakeholders, approvals and processes involved—and have a credible pathway from a successful pilot to funding, procurement and routine adoption.

By listening you'll discover:

How do you get an NHS clinician to trial your MedTech product and then turn that clinical interest into adoption?

If you're trying to commercialise a MedTech product or export a medical device into the UK, getting NHS clinicians interested is only one part of the challenge. You need to understand how to approach clinicians, what makes them willing to evaluate a new technology, and what needs to happen inside the wider NHS organisation for that initial interest to progress towards procurement and adoption.

In this episode you'll discover:

When exporting your MedTech product to Europe, should you focus everything on one market first or test several countries at the same time?

That's exactly the unresolved question. We're not telling them the answer.

Choosing where to start in Europe isn't simply about finding the country with the biggest MedTech market. Different countries can have very different reimbursement pathways, adoption barriers, competition, KOL support and routes to market. In this Decision Point episode, Hakeem revisits his conversation with Laurent Laffineur to explore whether your European export strategy should focus on one market, test several carefully...

If you're planning to export your MedTech product to Europe, how do you decide which countries you should actually enter first?

This doesn't assume they're making a mistake. It poses the central decision the episode helps them make.

Europe may look like one export opportunity on a map, but the commercial reality can be very different from country to country. Reimbursement, clinician adoption, buying pathways, language, culture and routes to market can all change as you cross a border. In this episode, Hakeem speaks with Laurent Laffineur, founder of Prime MedTech, about how to build...

Are you spending too much time telling customers about your MedTech product and not enough time talking about the problem they actually care about?

When you've spent years developing a medical device, it's natural to want to talk about the technology, the clinical evidence and why you built it. But your customers haven't been on that journey with you. If you're trying to commercialise or export your MedTech product, your go-to-market strategy needs to start with the problem through the customer's eyes, the value of solving it and whether that value is strong enough to make them...

How do you know whether your MedTech commercialisation strategy is actually working?

Regulatory approval, clinical evidence, distributor appointments, customer meetings and even your first sale can all feel like signs of commercial progress. But for MedTech founders trying to build, commercialise and eventually export a medical device, there's a difference between creating the conditions for commercial success and proving you have a sustainable business. In this episode, Hakeem uses an unlikely lesson from 90s hip-hop to explore what really counts as commercial success—and why the ability to repeat a sale matters so much.

In th...

How do you know which international markets actually give your MedTech product the best chance of success?

This avoids the problem we've discussed before: it doesn't tell the listener what they're doing wrong. It opens the question the episode answers.

When you're ready to export your MedTech product, it's tempting to start with the biggest healthcare markets, the fastest-growing countries or places where you already know distributors. But the right export market for one medical device could be completely wrong for another. In this episode, Hakeem explains why effective international market selection starts...

Your medical device has regulatory approval, clinical evidence and manufacturing in place but does that actually mean customers are ready to buy it?

This doesn't diagnose their problem. It challenges the assumption that the three green ticks automatically equal commercial readiness.

A MedTech product can be completely ready to launch and still not be commercially ready to sell. Before spending heavily on salespeople, distributors, exhibitions or new export markets, you need to know whether customers have genuine demand, how your medical device actually gets bought, and what could make adoption harder than expected. In this...

If you had £500,000 to enter the US with your MedTech product, where would you spend it first?

For clinician founders looking to export a medical device to the US, the size of the opportunity can make it tempting to think big from day one. But entering the US MedTech market and scaling across it are two very different decisions. In this episode, Hakeem and international growth and commercialisation consultant Craig T. Ingram explore whether you should build a US sales team, appoint a distributor, raise more capital or prove your commercial model in one defined market segment f...

What if spending more money on sales isn't actually the fastest way to grow your MedTech business?

For clinician founders looking to commercialise and export a medical device internationally, growing a MedTech business takes more than regulatory approval, investment and an expensive sales team. If the market doesn't understand the problem your product solves or have a reason to change, adding salespeople can simply increase your burn rate without increasing adoption. In this episode, Hakeem speaks with international growth and commercialisation consultant Craig T. Ingram about creating demand before launch, entering new export markets and building a...

Thinking about exporting your MedTech product to the GCC? Are you actually ready to build a market there or are you simply looking for a distributor?

Successfully exporting a MedTech product to the GCC takes more than appointing a distributor and waiting for sales. You need clear clinical value, the right commercial partner, a plan for creating demand, meaningful measures of early progress, and ongoing manufacturer support. In this episode, Hakeem shares five key lessons from his conversation with experienced GCC distributor Sameh Salama to help you prepare for commercialisation, adoption and sustainable sales across the region.<...

If a great export distributor had four MedTech products to choose from today, why would they choose yours?

MedTech manufacturers spend a lot of time asking whether a distributor is capable of selling their product. But there's another question that's just as important: why should a good distributor choose you? Taking on your product means investing their sales time, clinical resources, customer relationships, marketing activity and reputation. In this episode, Hakeem unpacks a real decision with experienced GCC distributor Sameh Salama to reveal what good export distributors actually look for before deciding whether a MedTech product represents...

Thinking about exporting your MedTech product to the GCC? What if finding a great distributor is only the beginning of what you need to succeed?

The GCC can be an attractive export market for MedTech companies, but you can't simply take the strategy that worked in the UK, Europe or US, appoint a distributor and expect the same results. In this episode, Hakeem speaks with GCC MedTech distributor Sameh Salama about what manufacturers need to understand before entering the region, from choosing the right commercial partner and navigating local purchasing dynamics to clinical education, KOL engagement and...

If your MedTech product isn't selling as quickly as expected, are more salespeople really going to fix the problem?

When a MedTech launch underperforms, hiring more salespeople, recruiting another distributor or attending more exhibitions can feel like the obvious answer. But if the market hasn't been prepared and customers don't yet see a compelling reason to change, more sales activity won't solve the underlying problem. In this episode, Hakeem explains why successful MedTech commercialisation and export starts long before launch—and why understanding and preparing your market can save you from trying to force adoption later.

...

Are you pricing your MedTech product based on evidence and value... or simply making an educated guess?

Pricing is one of the most important commercial decisions you'll make, yet many MedTech founders spend years developing their product and only a few hours deciding what it's should cost. In this episode, Hakeem shares a practical five-step framework to help you understand your market, quantify your value, validate your pricing, and develop a pricing strategy that supports successful commercialisation and export.

In this episode, you'll discover:

Is your MedTech product genuinely ready for commercialisation and export, or are you simply working through a checklist?

Many MedTech founders believe that regulatory approval, clinical evidence, patents, and distributor interest mean they're ready for commercial success. But commercial readiness is about far more than ticking boxes. In this episode, Hakeem explains why successful commercialisation depends on multiple factors working together and introduces a structured way of assessing whether your MedTech product is truly ready for commercialisation and export before investing significant time and money.

In this episode, you'll discover:

What do clinicians actually want before they'll adopt your MedTech product?

Many MedTech founders focus on product features, clinical evidence, and regulatory approval, believing these alone will drive adoption. But clinicians evaluate new technologies through a very different lens. In this episode, Hakeem shares the five biggest lessons from his conversation with Dr Tangwan Azorfor, giving you a clinician's perspective on what really influences adoption and how you can better align your commercialisation strategy with the realities of clinical practice.

In this episode, you'll discover:

If your MedTech product already has strong clinical evidence, why are clinicians still hesitant to adopt it?

Many MedTech founders assume that if adoption is slow, the answer is to generate more clinical evidence. But from a clinician's perspective, the real barrier is often confidence rather than proof. In this episode, Hakeem unpacks a real commercial decision with consultant cardiologist Dr Tang Wan, revealing why trusted local reference sites can have a greater influence on adoption than another published study, and how founders should use this insight to strengthen their commercialisation strategy.

In this episode...

Have you ever stopped to ask yourself how clinicians really decide whether to adopt a new MedTech product?

Understanding how clinicians make decisions is one of the most overlooked aspects of MedTech commercialisation. Product features and clinical evidence matter, but they're only part of the decision. In this episode, Hakeem explores what really influences clinician adoption, from patient outcomes and workflow to trust, ease of use, and perceived value, helping MedTech founders better prepare their products for commercial success.

In this episode, you'll discover:

Could the wrong export distributor cost your MedTech business years of growth?

Choosing an export distributor is one of the biggest commercial decisions a MedTech company will make. Yet many founders focus on impressive presentations instead of proven capability, give away exclusivity too early, or mistake a distributor for a complete go-to-market strategy. In this episode, Hakeem shares the five most common mistakes he sees and explains how to choose a distributor who becomes a genuine commercial partner.

Listeners will discover:

What if the success of your MedTech product was determined months before launch?

Many MedTech founders believe that strong clinical evidence and a great product are enough to drive adoption. In reality, successful launches begin long before launch day. In this episode, Hakeem shares the five biggest lessons from his conversation with Holly Miller, revealing how to prepare the market, build demand, and move your product from a "nice-to-have" to a "must-have."

Listeners will discover:

What if the success of your MedTech product is decided months before you ever launch it?

Many clinician founders believe commercialisation begins once regulatory approval is achieved and the product reaches the market. In reality, the companies that achieve the strongest adoption are already building demand, educating the market, and creating advocates long before launch. In this episode, Hakeem unpacks Holly Miller's decision-making framework and explains why belief—not just evidence—is the foundation of successful MedTech adoption.

Listeners will discover:

Have you ever wondered why a clinically proven MedTech product can achieve regulatory approval, generate positive feedback, and still fail commercially?

Many clinician founders believe that strong clinical evidence is enough to drive adoption. Unfortunately, healthcare doesn't work that way. In this episode, Hakeem speaks with Holly Miller about why adoption is engineered long before launch and how behavioural science, market conditioning, and stakeholder alignment help transform innovative MedTech products from interesting ideas into the new standard of care.

Listeners will discover:

Regulation gets you approved. A go-to-market strategy gets you adopted.

The question is: are you spending more time preparing your medical device for approval than preparing it for commercial success?

Many clinician founders believe launching a medical device starts with regulation, manufacturing, or raising investment. But by the time you're thinking about those things, many of the decisions that determine commercial success have already been made. In this episode, Hakeem shares a practical seven-step framework to help you validate the problem, build the right evidence, develop a go-to-market strategy, and create the foundations for successful...

Have you ever wondered why some MedTech products achieve adoption and international success, while others never make it beyond regulatory approval?

Many clinicians believe that solving a genuine clinical problem is enough to build a successful MedTech business. In reality, commercial success starts long before regulatory approval. In this episode, Hakeem shares five key lessons from his conversation with Jordan Morrison, covering the mindset, commercial strategy, funding, and adoption principles that help turn innovative ideas into commercially successful MedTech products ready for export markets.

Listeners will discover:

Are broad product claims slowing down your MedTech product's route to market without you even realising it?

Many MedTech companies assume that regulatory delays mean they need more clinical evidence, more funding, or more time. But in many cases, the real issue is that their product claims are broader than the evidence they already have. In this episode, Hakeem unpacks Jordan Morrison's decision-making framework and explains why narrowing your claims could help you achieve regulatory approval, generate revenue sooner, and build momentum for future growth.

Listeners will discover:

Have you ever built a MedTech solution that clinicians praised, only to discover that praise doesn't automatically lead to adoption, funding, or sales?

Many clinician founders believe that solving a genuine clinical problem is enough to guarantee success. Unfortunately, healthcare is full of innovative products that never make it beyond a pilot programme. In this episode, Jordan Morrison explains why adoption must be designed into your MedTech product from day one and how founders can avoid the common traps that prevent great innovations from reaching patients.

Listeners will discover:

Are you focusing on distributors, regulations, and trade shows before you've even confirmed that Japan is the right market for your MedTech product?

Many MedTech companies approach Japan by immediately looking for distributors, regulatory support, or commercial partners. But as Hakeem explains in this episode, the most successful companies start somewhere else entirely. Drawing on key lessons from his conversation with Japan market expert Curt Jennewine, this episode explores how to evaluate market opportunity, avoid costly assumptions, and build a market-entry strategy that matches your resources and objectives.

Listeners will discover: